[James_Lilly911 (OP)]

Hi there folks. I am interested if anybody has more information or know sources where I can read more about a new drug called Kymriah (tisagenlecleucel) by Novartis.


In general, this drug is a brand new way of Oncology diseases treatment especially acute lymphoblastic leukemia and others that need hematopoietic cells transplantation or have a high risk of relapse. If someone knows something special about CTR or such info, please share Also, let's discuss 

[chris]

Hello James; welcome to the forum.

We discussed Kymriah on the Naked Scientists when it was licensed in September 2017.

I wrote this summary of Kymriah and how cell reprogramming therapies work.
 
We also spoke to Magda Papadaki, from the Association of the British Pharmaceutical Industry, who explained, in layman's terms more about how Kymriah works.

I hope those links are helpful. Please give them a read and then return here with any follow up questions that you may have.

Chris